
Genetic Engineering News (GEN)
Now in its 27th year, Genetic Engineering & Biotechnology News (GEN) retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D.
Genetic Engineering & Biotechnology News, the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide.

GenomeWeb's editorial mission is to serve readers with exclusive, in-depth coverage of the technology, institutions, and scientists that make up the worldwide research enterprise of molecular biology.

Coverage includes proteomics; protein biomarker discovery; mass spectrometry; chromatography; protein arrays; separations and quantitative methods; diagnostic development; US and European regulatory issues; standards; and more.

Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved